Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Barbara Andraka-Christou

Biographic Data

ID379225
NAMEBarbara Andraka-Christou
GIVEN NAMESBarbara
FAMILY NAMEAndraka-Christou
SIGNATUREANDRAKA-CHRISTOU B
AFFILIATIONSUniversity of Central Florida
ORCID0000-0001-6307-6369
VERIFIEDYes
TOTAL WORKS19
TOTAL CITATIONS3
AUTHOR COUNT19
EDITOR COUNT0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2026
H-INDEX1
  • Factors Affecting Accessibility of Campus-Based Substance Use Disorder Treatment in a U.S. College Sample

    Fatema Z Ahmed, Barbara Andraka-Christou et al.•ARTICLE•Substance Use & Misuse•2026

    BACKGROUND: College students comprise a substantial proportion of young adults in the United States, the age group with the highest prevalence of substance use disorder (SUD). Although campus-based SUD treatment can support students' health and academic success, these services are often underutilized. Understanding barriers and facilitators to access from both student and staff perspectives is critical. METHODS: We conducted a qualitative study u…

  • Analyzing the Discursive Framing of Medications for Opioid Use Disorder (Mouds) in U.S. News Media: A Comparative Study of Benefits, Persuasion Methods, and Temporal Trends

    Fatema Z Ahmed, Olivia K Golan et al.•ARTICLE•Health Communication•2026

    Medications for opioid use disorder (MOUDs) offer substantial benefits but are underutilized. Media representations of MOUD benefits potentially shape public and policymaker attitudes toward these treatments. This study examines how MOUD benefits are portrayed in the news media, exploring variations by medication type, publication period, news source, and persuasion approach. We analyzed 81 articles from the New York Times, USA Today, and Fox New…

  • The role of social relationships in recovery court programs

    Open Access•Emma Katherine Dudley, Barbara Andraka-Christou et al.•ARTICLE•Health & Justice•2025

    BACKGROUND: Recovery courts offer an empirically supported alternative to incarceration for legally involved individuals struggling with addiction. While studies suggest that graduation from recovery courts leads to a lower likelihood of recidivism as compared to incarceration, attrition rates among recovery court participants are high. Relatively little is known about how court participants' social and family interactions affect progression thro…

  • Beliefs of US chiefs of police about substance use disorder, fentanyl exposure, overdose response, and use of discretion: Results from a national survey

    Open Access•Amelia Bailey, Barbara Andraka-Christou et al.•ARTICLE•Health & Justice•2025

  • Treatment Court Staffs’ Perceptions in Support of the Use of Virtual Services in Court Post-Pandemic

    Open Access•Meghan M O’Neil, Barbara Andraka-Christou et al.•ARTICLE•Criminal Justice and Behavior•2024

    The COVID-19 pandemic disrupted traditional courthouse operations, resulting in the abrupt and extensive adoption of virtual court proceedings. To date, limited empirical research has evaluated virtual treatment courts. Utilizing a novel national survey administered to 358 treatment court team members, we examine support for and barriers to virtual courts. Tested barriers include (a) access to technology, (b) Wi-Fi/internet, (c) private space to …

  • The effects of message framing on US police chiefs’ support for interventions for opioid use disorder: A randomized survey experiment

    Open Access•Brandon Del Pozo, Saba Rouhani et al.•ARTICLE•Health & Justice•2024

  • Impact of Covid-19 on Florida family dependency drug courts

    Open Access•Olivia K Golan, Fatema Z Ahmed et al.•ARTICLE•Health & Justice•2024

  • Disparities in the accuracy of reporting opioid overdoses to 9-1-1 by race and sex of overdose victim, Marion County, Indiana, 2011–2020

    Open Access•Danielle N Atkins, Brandon Del Pozo et al.•ARTICLE•Health & Justice•2024

  • Legal Limitations Associated with Microdosing Buprenorphine

    Barbara Andraka-Christou, Matthew Douglas Evans et al.•ARTICLE•Substance Use & Misuse•2023

    Background: Opioid overdose deaths in the U.S. continue to increase, largely due to the prevalence of fentanyl, a very powerful opioid, in the illicit drug supply. Buprenorphine treatment is effective for treating opioid use disorder, but it can be challenging for clinicians to introduce buprenorphine treatment to people who use fentanyl due to risks of precipitated withdrawal. Induction could be facilitated through a buprenorphine microdosing ap…

  • Problem-Solving Court Staff Preferences for Educational Videos about Medications for Opioid Use Disorder

    Barbara Andraka-Christou, Yara Asi et al.•ARTICLE•Substance Use & Misuse•2023

    Problem-solving courts use an interdisciplinary approach with treatment mandates, hearings, and monitoring to rehabilitate individuals arrested for drug-related crimes or lost custody of children due to drug use. Medications for opioid use disorder (MOUD) are the standard of care for treating opioid use disorder (OUD), but few problem-solving court clients with OUD are referred to MOUD. Previous studies found court staff often harbor misconceptio…

  • Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment

    Open Access•Bradley D Stein, Brendan Saloner et al.•ARTICLE•JAMA Health Forum•2023

    In this cross-sectional study of US pharmacy claims, state-mandated educational requirements beyond the initial training required to prescribe buprenorphine were associated with increased buprenorphine use over time. The findings suggest requiring education for buprenorphine prescribers and training in substance use disorder treatment for all controlled substance prescribers as an actionable proposal for increasing buprenorphine use, ultimately s…

  • A national survey of state laws regarding medications for opioid use disorder in problem-solving courts

    Open Access•Barbara Andraka-Christou, Olivia Randall-Kosich et al.•ARTICLE•Health & Justice•2022

  • Harm Reduction Policy Support among Students at Two U.S. Universities

    Barbara Andraka-Christou, Thuy Dieu Nguyen et al.•ARTICLE•Substance Use & Misuse•2022

    Background: The U.S. is undergoing an opioid overdose crisis. Harm reduction (HR) policies are associated with decreased overdose deaths and incidence of communicable diseases, yet legality of HR policies differs across U.S. jurisdictions. College student perceptions of HR policies are underexplored, even though their voting behavior has increased in recent years. We sought to compare their support of different HR policies and to explore relation…

  • Barriers to medications for opioid use disorder in the court system: Provider availability, provider “trustworthiness,” and cost

    Open Access•Fatema Z Ahmed, Barbara Andraka-Christou et al.•ARTICLE•Health & Justice•2022

  • Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021

    Open Access•Thuy Dieu Nguyen, Kao‐Ping Chua et al.•ARTICLE•JAMA Health Forum•2022

    This cross-sectional study assesses buprenorphine coverage and prior authorization requirements in US commercial formulary data from 2017 to 2021

  • Isomorphic Pressures on Jail Diversion: From Serious Mental Illness to Opioid Use Disorder

    Open Access•Monte Staton, Monte D Staton et al.•ARTICLE•The Prison Journal•2021

    This article explains how jail diversion introduced in one Midwestern county changed its focus over time from persons with serious mental illness (PSMI) to persons with opioid use disorder (POUD). Applying the theory of institutional isomorphism, the authors use both qualitative interview and quantitative program data to explore the isomorphic pressures that caused programming change resulting from an opioid addiction crisis at the expense of arr…

  • Designing an "Ideal" Substance Use Disorder Treatment Center: Perspectives of People Who Have Utilized Medications for Opioid Use Disorder

    Open Access•Barbara Andraka-Christou, Olivia Randall-Kosich et al.•ARTICLE•Qualitative Health Research•2021•Cited by: 3•References: 52

    Treatment preferences of people with opioid use disorder (OUD) have been underexplored, especially among those with a history of utilizing medications for opioid use disorder (MOUD). Therefore, we sought to understand preferred characteristics of substance use disorder treatment centers among people recovering from OUD with a history of MOUD utilization. We recruited 30 individuals from eight states through snowball sampling initiated at three sy…

  • Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem‐solving and dependency court staff

    Open Access•Barbara Andraka-Christou, Danielle N Atkins et al.•ARTICLE•Drug and Alcohol Review•2020

  • A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices

    Open Access•Barbara Andraka-Christou, Matthew J Capone•ARTICLE•International Journal of Drug…•2018

  • Designing an "Ideal" Substance Use Disorder Treatment Center: Perspectives of People Who Have Utilized Medications for Opioid Use Disorder

    Open Access•Barbara Andraka-Christou, Olivia Randall-Kosich et al.•ARTICLE•Qualitative Health Research•2021•Cited by: 3•References: 52

    Treatment preferences of people with opioid use disorder (OUD) have been underexplored, especially among those with a history of utilizing medications for opioid use disorder (MOUD). Therefore, we sought to understand preferred characteristics of substance use disorder treatment centers among people recovering from OUD with a history of MOUD utilization. We recruited 30 individuals from eight states through snowball sampling initiated at three sy…

  • A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices

    Open Access•Barbara Andraka-Christou, Matthew J Capone•ARTICLE•International Journal of Drug…•2018

  • Receipt of training about medication for opioid use disorder from pharmaceutical manufacturers: A preliminary study of Florida criminal problem‐solving and dependency court staff

    Open Access•Barbara Andraka-Christou, Danielle N Atkins et al.•ARTICLE•Drug and Alcohol Review•2020

  • Isomorphic Pressures on Jail Diversion: From Serious Mental Illness to Opioid Use Disorder

    Open Access•Monte Staton, Monte D Staton et al.•ARTICLE•The Prison Journal•2021

    This article explains how jail diversion introduced in one Midwestern county changed its focus over time from persons with serious mental illness (PSMI) to persons with opioid use disorder (POUD). Applying the theory of institutional isomorphism, the authors use both qualitative interview and quantitative program data to explore the isomorphic pressures that caused programming change resulting from an opioid addiction crisis at the expense of arr…

  • Designing an "Ideal" Substance Use Disorder Treatment Center: Perspectives of People Who Have Utilized Medications for Opioid Use Disorder

    Open Access•Barbara Andraka-Christou, Olivia Randall-Kosich et al.•ARTICLE•Qualitative Health Research•2021•Cited by: 3•References: 52

    Treatment preferences of people with opioid use disorder (OUD) have been underexplored, especially among those with a history of utilizing medications for opioid use disorder (MOUD). Therefore, we sought to understand preferred characteristics of substance use disorder treatment centers among people recovering from OUD with a history of MOUD utilization. We recruited 30 individuals from eight states through snowball sampling initiated at three sy…

  • A national survey of state laws regarding medications for opioid use disorder in problem-solving courts

    Open Access•Barbara Andraka-Christou, Olivia Randall-Kosich et al.•ARTICLE•Health & Justice•2022

  • Harm Reduction Policy Support among Students at Two U.S. Universities

    Barbara Andraka-Christou, Thuy Dieu Nguyen et al.•ARTICLE•Substance Use & Misuse•2022

    Background: The U.S. is undergoing an opioid overdose crisis. Harm reduction (HR) policies are associated with decreased overdose deaths and incidence of communicable diseases, yet legality of HR policies differs across U.S. jurisdictions. College student perceptions of HR policies are underexplored, even though their voting behavior has increased in recent years. We sought to compare their support of different HR policies and to explore relation…

  • Barriers to medications for opioid use disorder in the court system: Provider availability, provider “trustworthiness,” and cost

    Open Access•Fatema Z Ahmed, Barbara Andraka-Christou et al.•ARTICLE•Health & Justice•2022

  • Trends in Buprenorphine Coverage and Prior Authorization Requirements in US Commercial Formularies, 2017-2021

    Open Access•Thuy Dieu Nguyen, Kao‐Ping Chua et al.•ARTICLE•JAMA Health Forum•2022

    This cross-sectional study assesses buprenorphine coverage and prior authorization requirements in US commercial formulary data from 2017 to 2021

  • Legal Limitations Associated with Microdosing Buprenorphine

    Barbara Andraka-Christou, Matthew Douglas Evans et al.•ARTICLE•Substance Use & Misuse•2023

    Background: Opioid overdose deaths in the U.S. continue to increase, largely due to the prevalence of fentanyl, a very powerful opioid, in the illicit drug supply. Buprenorphine treatment is effective for treating opioid use disorder, but it can be challenging for clinicians to introduce buprenorphine treatment to people who use fentanyl due to risks of precipitated withdrawal. Induction could be facilitated through a buprenorphine microdosing ap…

  • Problem-Solving Court Staff Preferences for Educational Videos about Medications for Opioid Use Disorder

    Barbara Andraka-Christou, Yara Asi et al.•ARTICLE•Substance Use & Misuse•2023

    Problem-solving courts use an interdisciplinary approach with treatment mandates, hearings, and monitoring to rehabilitate individuals arrested for drug-related crimes or lost custody of children due to drug use. Medications for opioid use disorder (MOUD) are the standard of care for treating opioid use disorder (OUD), but few problem-solving court clients with OUD are referred to MOUD. Previous studies found court staff often harbor misconceptio…

  • Association of Selected State Policies and Requirements for Buprenorphine Treatment With Per Capita Months of Treatment

    Open Access•Bradley D Stein, Brendan Saloner et al.•ARTICLE•JAMA Health Forum•2023

    In this cross-sectional study of US pharmacy claims, state-mandated educational requirements beyond the initial training required to prescribe buprenorphine were associated with increased buprenorphine use over time. The findings suggest requiring education for buprenorphine prescribers and training in substance use disorder treatment for all controlled substance prescribers as an actionable proposal for increasing buprenorphine use, ultimately s…

  • Treatment Court Staffs’ Perceptions in Support of the Use of Virtual Services in Court Post-Pandemic

    Open Access•Meghan M O’Neil, Barbara Andraka-Christou et al.•ARTICLE•Criminal Justice and Behavior•2024

    The COVID-19 pandemic disrupted traditional courthouse operations, resulting in the abrupt and extensive adoption of virtual court proceedings. To date, limited empirical research has evaluated virtual treatment courts. Utilizing a novel national survey administered to 358 treatment court team members, we examine support for and barriers to virtual courts. Tested barriers include (a) access to technology, (b) Wi-Fi/internet, (c) private space to …

  • The effects of message framing on US police chiefs’ support for interventions for opioid use disorder: A randomized survey experiment

    Open Access•Brandon Del Pozo, Saba Rouhani et al.•ARTICLE•Health & Justice•2024

  • Impact of Covid-19 on Florida family dependency drug courts

    Open Access•Olivia K Golan, Fatema Z Ahmed et al.•ARTICLE•Health & Justice•2024

  • Disparities in the accuracy of reporting opioid overdoses to 9-1-1 by race and sex of overdose victim, Marion County, Indiana, 2011–2020

    Open Access•Danielle N Atkins, Brandon Del Pozo et al.•ARTICLE•Health & Justice•2024

  • The role of social relationships in recovery court programs

    Open Access•Emma Katherine Dudley, Barbara Andraka-Christou et al.•ARTICLE•Health & Justice•2025

    BACKGROUND: Recovery courts offer an empirically supported alternative to incarceration for legally involved individuals struggling with addiction. While studies suggest that graduation from recovery courts leads to a lower likelihood of recidivism as compared to incarceration, attrition rates among recovery court participants are high. Relatively little is known about how court participants' social and family interactions affect progression thro…

  • Beliefs of US chiefs of police about substance use disorder, fentanyl exposure, overdose response, and use of discretion: Results from a national survey

    Open Access•Amelia Bailey, Barbara Andraka-Christou et al.•ARTICLE•Health & Justice•2025

  • Factors Affecting Accessibility of Campus-Based Substance Use Disorder Treatment in a U.S. College Sample

    Fatema Z Ahmed, Barbara Andraka-Christou et al.•ARTICLE•Substance Use & Misuse•2026

    BACKGROUND: College students comprise a substantial proportion of young adults in the United States, the age group with the highest prevalence of substance use disorder (SUD). Although campus-based SUD treatment can support students' health and academic success, these services are often underutilized. Understanding barriers and facilitators to access from both student and staff perspectives is critical. METHODS: We conducted a qualitative study u…

  • Analyzing the Discursive Framing of Medications for Opioid Use Disorder (Mouds) in U.S. News Media: A Comparative Study of Benefits, Persuasion Methods, and Temporal Trends

    Fatema Z Ahmed, Olivia K Golan et al.•ARTICLE•Health Communication•2026

    Medications for opioid use disorder (MOUDs) offer substantial benefits but are underutilized. Media representations of MOUD benefits potentially shape public and policymaker attitudes toward these treatments. This study examines how MOUD benefits are portrayed in the news media, exploring variations by medication type, publication period, news source, and persuasion approach. We analyzed 81 articles from the New York Times, USA Today, and Fox New…

Medicine (15 works) · Opioid Use Disorder Treatment (14 works) · Substance Abuse Treatment and Outcomes (14 works) · Psychology (11 works) · Opioid (10 works) · Psychiatry (9 works) · Nursing (8 works) · Political science (8 works) · HIV, Drug Use, Sexual Risk (7 works) · Opioid use disorder (6 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae